Document Detail

Improvement of the bioavailability of colchicine in rats by co-administration of D-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid.
MedLine Citation:
PMID:  12404883     Owner:  NLM     Status:  MEDLINE    
Two surface-active formulation ingredients, a water-soluble derivative of vitamin E (D-alpha-tocopherol polyethylene glycol 1000 succinate, vitamin E-TPGS) as well as a polyethoxylated derivative of 12-hydroxy-stearic acid (Solutol HS 15) were investigated in rats for their potential to increase the oral bioavailability of the p-glycoprotein (p-gp) and cytochrome P450 substrate colchicine. D-alpha-Tocopherol polyethylene glycol 1000 succinate and the polyethoxylated derivative of 12-hydroxy-stearic acid will be referred to as "surfactant 1" and "surfactant 2" in the following. Colchicine was administered to the animals at a dose level of 5 mg/kg in each 10% surfactant containing formulation. A solution of colchicine in isotonic saline was selected as a reference formulation. It was found that the administration of colchicine in the surfactant containing formulations resulted in significantly higher systemic exposures as compared to the aqueous reference vehicle (2-fold increase in AUC in the presence of surfactant 1 and 4-fold increase in AUC in the presence of surfactant 2). The aqueous solubility of colchicine was about 16.7 mg/ml, and the increase in solubility in the presence of 1% surfactant 1 or surfactant 2 to about 20.5 and 18.5 mg/ml was not considered to significantly affect the oral bioavailability. In summary, it was demonstrated that both surfactants are suitable formulation ingredients to improve the systemic exposure of colchicine in the rat. Due to the high aqueous solubility of colchicine the most likely reasons for these findings are inhibition of p-gp and/or metabolism as well as permeability enhancement by interactions of the surfactants with the intestinal membrane.
Beate Bittner; Alberto Guenzi; Pascal Fullhardt; Gerhard Zuercher; Roberto Carlos Bravo González; Richard Jolyon Mountfield
Related Documents :
7547433 - The characterization of a rabbit model of inflammatory bowel disease.
15558643 - Evaluation of the local irritation potential of hypertonic saline-dextran (hsd) in mice...
17675663 - A phantom for effective dose measurement: organ dose distribution assessment based on a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Arzneimittel-Forschung     Volume:  52     ISSN:  0004-4172     ISO Abbreviation:  Arzneimittelforschung     Publication Date:  2002  
Date Detail:
Created Date:  2002-10-30     Completed Date:  2002-11-26     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0372660     Medline TA:  Arzneimittelforschung     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  684-8     Citation Subset:  IM    
Pharma Division, DMPK Discovery Support, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antioxidants / pharmacology*
Area Under Curve
Biological Availability
Chromatography, High Pressure Liquid
Colchicine / pharmacokinetics*
Cytochrome P-450 Enzyme System / metabolism
Intestinal Absorption / drug effects
Intestines / drug effects,  metabolism
P-Glycoprotein / metabolism
Rats, Wistar
Stearic Acids / pharmacology*
Stimulation, Chemical
Succinates / pharmacology*
Surface-Active Agents / pharmacology*
Vitamin E / analogs & derivatives,  pharmacology*
alpha-Tocopherol / pharmacology*
Reg. No./Substance:
0/Antioxidants; 0/P-Glycoprotein; 0/Stearic Acids; 0/Succinates; 0/Surface-Active Agents; 0/tocopherol polyethylene glycol succinate; 1406-18-4/Vitamin E; 59-02-9/alpha-Tocopherol; 64-86-8/Colchicine; 9035-51-2/Cytochrome P-450 Enzyme System

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Volume independent stimulation of renin secretion by a single dose of amiloride in man.
Next Document:  Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy vol...